| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0002 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0008 |